共 101 条
[1]
Barone P(2002)Guidelines for the treatment of Parkinson’s disease Clin Neurol 42 430-494
[2]
Scarzella L(2006)Pramipexole versus sertraline in the treatment of depression in Parkinson’s disease: a national multicenter parallel-group randomized study J Neurol 253 601-607
[3]
Marconi R(1978)Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness Drugs 16 273-301
[4]
Antonini A(1999)Comparison of the functional potencies of ropinirole and other dopamine receptor agonists at human D2 (long), D3 and D4.4 receptors expressed in Chinese hamster ovary cells Br J Pharmacol 127 1696-1702
[5]
Morgante L(2007)Electroconvulsive therapy for neurological disorders Brain Nerve 59 313-320
[6]
Bracco F(2004)Punding in Parkinson’s disease: its relation to the dopamine dysregulation syndrome Mov Disord 19 397-405
[7]
Zappia M(2000)Hallucinations in Parkinson’s disease. Prevalence, phenomenology and risk factors Brain 123 733-745
[8]
Musch B(2008)Impulse–control disorders in Parkinson’s disease CNS Spectra 13 690-698
[9]
Brogden RN(2007)Treating dopamimetic psychosis in Parkinson’s disease: structured review and meta-analysis Eur Neuropsychopharmacol 17 165-171
[10]
Heel RC(2004)Patient selection in stereotaxic neurosurgery for Parkinson’s disease: a guide to stereotactic brain operations Neurol Surg 32 1067-1075